Nancy C. Andrews
Nancy C. Andrews is the Nanaline H. Duke Professor of Pediatrics and Professor of Pharmacology and Cancer Biology at Duke University. From 2007 to 2017 she served as Dean of the Duke University School of Medicine and Vice Chancellor for Academic Affairs. Prior to moving to Duke she served as the George Richards Minot Professor of Pediatrics at Harvard University, senior associate in medicine at the Children’s Hospital Boston, and a distinguished physician of the Dana-Farber Cancer Institute. While at Harvard she was the director of the Harvard-MIT MD-Ph.D. Program and later Dean for Basic Sciences and Graduate Studies at Harvard Medical School. A pediatric hematologist-oncologist by training, her laboratory research focused on iron biology and mouse models of human diseases. She was a Howard Hughes Medical Institute Investigator from 1993 to 2006. She is the past president of the American Society of Clinical Investigation, a Member of the National Academy of Medicine and a Member of the National Academy of Sciences. She serves on the Boards of Directors of Novartis, Charles River Laboratories and Maze Therapeutics, and on the Executive Committee of the MIT Corporation. Andrews has been a committee member for both the Academy’s ARISE II report and the New Models for U.S. Science and Technology Policy project. She was elected a Fellow of the American Academy of Arts and Sciences in 2007 and serves as the Chair of its Board of Directors.